UDG Healthcare on Friday said US private equity firm Clayton Dubilier & Rice was considering an improved final offer of 1,080p a share for the company.
The two companies in May had agreed a 1,023p-a-share deal in May, valuing UDG at £2.6bn, but major shareholders, including Allianz Global Investors and M&G Investments, said the offer undervalued the Irish outfit.
CD&R said it would consider an improved offer if another firm decided to swoop for UDG, whose board said it would accept the latest bid if made.
